Innovent Biologics
1801.HK
#1182
Rank
โ‚น1.782 T
Marketcap
โ‚น1,022
Share price
2.26%
Change (1 day)
-1.33%
Change (1 year)

Revenue for Innovent Biologics (1801.HK)

Revenue in 2025: โ‚น174.22 Billion

According to Innovent Biologics's latest financial reports the company's current revenue (TTM ) is โ‚น174.22 Billion. In 2025 the company made a revenue of โ‚น174.22 Billion an increase over the revenue in the year 2024 that were of โ‚น120.65 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Innovent Biologics from 2016 to 2025

Annual revenue

Year Revenue Change
2025โ‚น174.22 B44.39%
2024โ‚น120.65 B47.04%
2023โ‚น82.05 B32.9%
2022โ‚น61.74 B-1.41%
2021โ‚น62.62 B13.7%
2020โ‚น55.08 B293.02%
2019โ‚น14.01 B10781.66%
2018โ‚น0.12 B-51.64%
2017โ‚น0.26 B
2016N/A